William McClintock
About William McClintock
William McClintock serves as Independent Non‑Executive Director and Chairman of the Board at T Stamp Inc. (IDAI), with confirmed independence under Nasdaq rules; he also sits on the Audit Committee and chairs both the Compensation Committee and the Nominating & Corporate Governance Committee . The proxy does not disclose his age, education, or detailed biography, and specific tenure start date is not provided in the cited filings .
Past Roles
- No prior employment history or biographical background was disclosed for Mr. McClintock in the proxy statements reviewed .
External Roles
- No other public company directorships or external board roles for Mr. McClintock were disclosed in the proxy statements reviewed .
Board Governance
- Role: Chairman of the Board; Board leadership structure separates Chair and CEO roles; Board holds executive sessions of independent directors .
- Independence: Board determined Mr. McClintock is independent under Nasdaq rules (and Rule 10A‑3 for audit committee) .
- Committees:
- Audit Committee member (Chair: Charles Potts) .
- Compensation Committee chair; authorized to set management compensation and administer stock incentive/purchase plans; reviews compensation adviser independence .
- Nominating & Corporate Governance Committee chair; oversees director nominations, governance guidelines, director compensation, and Board/committee evaluations .
- Committee Interlocks: None; no executive officer served on another company’s compensation committee with reciprocal service to IDAI during 2021‑2025 .
- Attendance: No formal policy requiring attendance at shareholder meetings; annual meetings held in 2022, 2023, and January 2025; none in 2021 .
- Audit Oversight: Audit Committee pre‑approves audit/non‑audit services, oversees internal audit functions, and reviews related‑party transactions .
Fixed Compensation
- Director compensation disclosure is limited; the company reported aggregate director pay of $234k for the year ended December 31, 2024 across seven directors (individual retainers/chair fees/meeting fees not itemized in the proxy) .
Performance Compensation
- Company states it does not have a formal equity incentive plan, yet RSUs are granted and administered under Board authority; RSU vesting timing is disclosed for named executive officers, not specifically for directors .
| RSU/Equity Detail | FY 2023 (as of 12/31/2023) | FY 2024 (as of 12/31/2024) |
|---|---|---|
| Unvested RSUs (#) | 9,252 | 624 |
| Market Value ($) | $12,675 | $8,266 |
| Options Outstanding | None disclosed | None disclosed |
- Compensation Committee authorizations include administering stock incentive/purchase plans and reviewing adviser independence; no performance metric framework for director equity grants is disclosed (no TSR/EBITDA/ESG metrics specified for directors) .
Other Directorships & Interlocks
- Current public boards: Not disclosed for Mr. McClintock .
- Interlocks: Compensation Committee interlocks and insider participation noted as none .
Expertise & Qualifications
- The proxy does not provide Mr. McClintock’s educational background, professional credentials, or detailed expertise; he is positioned within Board leadership and on core governance committees, indicating governance oversight experience .
Equity Ownership
| Date (Reference) | Beneficially Owned Shares | Acquirable Within 60 Days | Percent of Class |
|---|---|---|---|
| Aug 31, 2024 | 41,472 | — | 0.24% |
| Sep 30, 2024 | 41,472 | — | 0.12% |
| Jan 29, 2025 | 2,781 | 624 | 0.07% |
| Sep 30, 2025 | 3,405 | — | 0.05% |
- Shares pledged as collateral: No pledging disclosed for Mr. McClintock .
- Stock ownership guidelines: Not disclosed; compliance status not disclosed .
Governance Assessment
-
Strengths:
- Separation of Chair and CEO; independent Chair enhances oversight and investor confidence .
- Independent status affirmed; participation across Audit, Compensation (chair), and Nominating & Governance (chair) strengthens governance controls and policy setting .
- Executive sessions of independent directors held regularly .
- Audit Committee explicitly oversees related‑party transactions and pre‑approves audit/non‑audit services .
-
Concerns/Watch‑Items:
- Concentration of governance power: Chairmanship combined with chair roles on Compensation and Nominating & Governance centralizes influence; may require strong counterbalances (e.g., lead independent director, robust committee charters) .
- Limited transparency: Proxy lacks itemized non‑employee director cash retainer, chair/meeting fees, and director‑specific performance metrics—reducing clarity on pay‑for‑performance alignment .
- Formal equity plan absent: Company states no formal equity incentive plan, yet grants RSUs; governance best practices typically favor formal plan structures approved by shareholders .
-
Related‑Party Transactions:
- Historic investor nomination right (FSH Capital) memorialized by Board; currently no director nominated pursuant to this right; no transactions disclosed involving Mr. McClintock specifically .
- Audit Committee tasked with reviewing/approving transactions with directors/officers/affiliates .
-
Legal/Red Flag Indicators:
- No litigation involving directors disclosed in the proxy .
- No compensation committee interlocks or insider participation reported .
- No pledging/hedging or tax gross‑ups disclosed for directors; say‑on‑pay results not discussed in these materials .
RED FLAGS: Centralized committee leadership by the Chair across Compensation and Nominating & Governance with limited disclosure of director cash compensation structure and absent formal equity plan could be perceived as governance risk without additional safeguards .